Effect of Mediterranean Diet in Inflammatory Bowel Disease

Part of paid clinical trials in San Diego, California.

Sponsor
University of California, San Diego
Study ID
NCT05973500
Status
Recruiting
Apply to this trial

Conditions

  • Inflammatory Bowel Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Mediterranean Diet — DIETARY_SUPPLEMENT
    Mediterranean Diet for 42 Days

Study Details

The effects of diet on inflammatory bowel disease is an under-studied area of research. The investigators are interested in further investigating the role that diet contributes to inflammatory bowel disease severity. The investigators will collect blood and stool samples from patients with inflammatory bowel disease (IBD) before and after diet changes. The stool samples will be analyzed using metabolomics and microbiome analysis to determine changes after the new diet has been implemented. The investigators will then compare changes in the patient's overall disease state by measuring markers of inflammation including C-reactive protein (CRP) and fecal calprotectin to determine how this diet affects the disease state.

Key Dates

Start date
Sep 1, 2023
Status verified
Apr 2024
Primary completion
Aug 1, 2028
Completion
Aug 1, 2028

Study Design

Enrollment
90 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Mediterranean Diet
    Mediterranean Diet for 42 Days

Primary Outcome Measure

short Crohn's Disease Activity Index (sCDAI) [ Time Frame: 42 Days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San DiegoSan DiegoCalifornia92161
Monica Guma, M.D, PHD
[email protected]
Brigid Boland, M.D (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Diego, CA

By research site
University of California, San Diego· San Diego, CA

Related Studies